ArticleJournal of cancer research and clinical oncology2022
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study.
Mutlu Hizal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.